Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Organometallic DNA-B12 Conjugates as Potential Oligonucleotide Vectors: Synthesis and Structural and Binding Studies with Human Cobalamin-Transport Proteins.

Mutti E, Hunger M, Fedosov S, Nexo E, Kräutler B.

Chembiochem. 2017 Nov 16;18(22):2280-2291. doi: 10.1002/cbic.201700472. Epub 2017 Oct 10.

PMID:
28881087
2.

Organometallic B12-DNA conjugate: synthesis, structure analysis, and studies of binding to human B12-transporter proteins.

Hunger M, Mutti E, Rieder A, Enders B, Nexo E, Kräutler B.

Chemistry. 2014 Oct 6;20(41):13103-7. doi: 10.1002/chem.201404359. Epub 2014 Aug 28.

PMID:
25168390
3.

4-ethylphenyl-cobalamin impairs tissue uptake of vitamin B12 and causes vitamin B12 deficiency in mice.

Mutti E, Ruetz M, Birn H, Kräutler B, Nexo E.

PLoS One. 2013 Sep 20;8(9):e75312. doi: 10.1371/journal.pone.0075312. eCollection 2013.

4.

Vitamin B₁₂ dependent changes in mouse spinal cord expression of vitamin B₁₂ related proteins and the epidermal growth factor system.

Mutti E, Lildballe DL, Kristensen L, Birn H, Nexo E.

Brain Res. 2013 Mar 29;1503:1-6. doi: 10.1016/j.brainres.2013.01.050. Epub 2013 Feb 8.

PMID:
23399680
5.

Maximal load of the vitamin B12 transport system: a study on mice treated for four weeks with high-dose vitamin B12 or cobinamide.

Lildballe DL, Mutti E, Birn H, Nexo E.

PLoS One. 2012;7(10):e46657. doi: 10.1371/journal.pone.0046657. Epub 2012 Oct 1.

6.

Mast cell infiltration discriminates between histopathological phenotypes of chronic obstructive pulmonary disease.

Ballarin A, Bazzan E, Zenteno RH, Turato G, Baraldo S, Zanovello D, Mutti E, Hogg JC, Saetta M, Cosio MG.

Am J Respir Crit Care Med. 2012 Aug 1;186(3):233-9. doi: 10.1164/rccm.201112-2142OC. Epub 2012 Jun 7.

PMID:
22679009
7.

Cobalamin (vitamin B(12)) regulation of PrP(C), PrP(C)-mRNA and copper levels in rat central nervous system.

Scalabrino G, Veber D, Mutti E, Calligaro A, Milani S, Tredici G.

Exp Neurol. 2012 Jan;233(1):380-90. doi: 10.1016/j.expneurol.2011.11.003. Epub 2011 Nov 12.

PMID:
22116041
8.

The octapeptide repeat PrP(C) region and cobalamin-deficient polyneuropathy of the rat.

Scalabrino G, Mutti E, Veber D, Rodriguez Menendez V, Novembrino C, Calligaro A, Tredici G.

Muscle Nerve. 2011 Dec;44(6):957-67. doi: 10.1002/mus.22225.

PMID:
22102467
9.

Cobalamin deficiency-induced changes of epidermal growth factor (EGF)-receptor expression and EGF levels in rat spinal cord.

Mutti E, Magnaghi V, Veber D, Faroni A, Pece S, Di Fiore PP, Scalabrino G.

Brain Res. 2011 Feb 28;1376:23-30. doi: 10.1016/j.brainres.2010.12.056. Epub 2010 Dec 23.

PMID:
21185268
10.

Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis.

Scalabrino G, Galimberti D, Mutti E, Scalabrini D, Veber D, De Riz M, Bamonti F, Capello E, Mancardi GL, Scarpini E.

Brain Res. 2010 May 28;1333:64-71. doi: 10.1016/j.brainres.2010.03.073. Epub 2010 Mar 27.

PMID:
20347721
11.

Cobalamin deficiency-induced changes in magnetic resonance imaging of cerebrospinal fluid volume in the cervical tract in the rat.

Veber D, Mutti E, Sironi L, Guerrini U, Gianazza E, Scalabrino G.

Neurosci Lett. 2008 Aug 8;440(3):202-5. doi: 10.1016/j.neulet.2008.05.079. Epub 2008 May 24.

PMID:
18571320
12.

Experimental and clinical evidence of the role of cytokines and growth factors in the pathogenesis of acquired cobalamin-deficient leukoneuropathy.

Scalabrino G, Veber D, Mutti E.

Brain Res Rev. 2008 Nov;59(1):42-54. doi: 10.1016/j.brainresrev.2008.05.001. Epub 2008 May 9. Review.

PMID:
18538413
13.

New pathogenesis of the cobalamin-deficient neuropathy.

Scalabrino G, Veber D, Mutti E.

Med Secoli. 2007;19(1):9-18.

PMID:
18447164
14.

Indirect down-regulation of nuclear NF-kappaB levels by cobalamin in the spinal cord and liver of the rat.

Veber D, Mutti E, Tacchini L, Gammella E, Tredici G, Scalabrino G.

J Neurosci Res. 2008 May 1;86(6):1380-7. doi: 10.1002/jnr.21599.

PMID:
18183619
15.

Cobalamin deficiency-induced down-regulation of p75-immunoreactive cell levels in rat central nervous system.

Mutti E, Veber D, Stampachiacchiere B, Triaca V, Gammella E, Tacchini L, Aloe L, Scalabrino G.

Brain Res. 2007 Jul 9;1157:92-9. Epub 2007 Apr 25. Erratum in: Brain Res. 2008 Jan 23;1190:225. Stampachiacchere, Barbara [corrected to Stampachiacchiere, Barbara].

PMID:
17524373
16.

Cobalamin-mediated regulation of transcobalamin receptor levels in rat organs.

Kalra S, Ahuja R, Mutti E, Veber D, Seetharam S, Scalabrino G, Seetharam B.

Arch Biochem Biophys. 2007 Jul 1;463(1):128-32. Epub 2007 Apr 2.

PMID:
17442257
17.

Increased levels of the CD40:CD40 ligand dyad in the cerebrospinal fluid of rats with vitamin B12(cobalamin)-deficient central neuropathy.

Veber D, Mutti E, Galmozzi E, Cedrola S, Galbiati S, Morabito A, Tredici G, La Porta CA, Scalabrino G.

J Neuroimmunol. 2006 Jul;176(1-2):24-33. Epub 2006 May 22.

PMID:
16716410
18.

[Peer review about gastro-esophageal reflux disease in primary care: epidemiology, diagnostic and therapeutic management].

Belleri G, Comini L, Ramponi GP, Tabaglio E, Archetti G, Astori P, Baldini S, Baronchelli M, Beltrami G, Benini F, Bertolotti B, Bettoncelli G, Bonardelli E, Bovini L, Chiappi A, Ferrari A, Guarnera L, Mauro N, Multineddu M, Mutti E, Palini S, Palumbo M, Pascarella A, Pellizzari R, Regazzoli T, Sidari G, Terranova FR, Zadra A, Zavanella D.

Recenti Prog Med. 2006 Feb;97(2):74-8. Italian.

PMID:
16671271
19.

Increased spinal cord NGF levels in rats with cobalamin (vitamin B12) deficiency.

Scalabrino G, Mutti E, Veber D, Aloe L, Corsi MM, Galbiati S, Tredici G.

Neurosci Lett. 2006 Mar 27;396(2):153-8. Epub 2005 Dec 13.

PMID:
16352395
20.

New basis of the neurotrophic action of vitamin B12.

Scalabrino G, Buccellato FR, Veber D, Mutti E.

Clin Chem Lab Med. 2003 Nov;41(11):1435-7. Review.

PMID:
14656022
21.

Cobalamin (vitamin B12)-deficiency-induced changes in the proteome of rat cerebrospinal fluid.

Gianazza E, Veber D, Eberini I, Buccellato FR, Mutti E, Sironi L, Scalabrino G.

Biochem J. 2003 Aug 15;374(Pt 1):239-46.

22.

Lack of effect of percutaneous transluminal renal angioplasty on nocturnal hypotension in renovascular hypertensive patients.

Ravogli A, Arzilli F, Omboni S, Giovannetti R, Mutti E, Salvetti A, Mancia G.

J Hypertens. 1996 Jan;14(1):53-6.

PMID:
12013495
23.

Ambulatory blood pressure monitoring in the evaluation of antihypertensive drugs.

Parati G, Ravogli A, Mutti E, Santucciu C, Omboni S, Mancia G.

J Hypertens Suppl. 1994 Nov;12(8):S9-15. Review.

PMID:
7707163
24.

Beta-adrenergic blocking treatment and 24-hour baroreflex sensitivity in essential hypertensive patients.

Parati G, Mutti E, Frattola A, Castiglioni P, di Rienzo M, Mancia G.

Hypertension. 1994 Jun;23(6 Pt 2):992-6.

PMID:
7911452
25.

Spectral and sequence analysis of finger blood pressure variability. Comparison with analysis of intra-arterial recordings.

Omboni S, Parati G, Frattola A, Mutti E, Di Rienzo M, Castiglioni P, Mancia G.

Hypertension. 1993 Jul;22(1):26-33.

PMID:
8319990
26.
27.

Changes in 24 hour blood pressure and in cardiac and vascular structure in normotensive subjects with parental hypertension.

Parati G, Ravogli A, Giannattasio C, Mutti E, Trazzi S, Villani A, Mancia G.

Clin Exp Hypertens A. 1992;14(1-2):67-83.

PMID:
1541048
28.

Acute modulation of arterial compliance in mild essential hypertension.

Trazzi S, Omboni S, Mutti E, Parati G, Zanchetti A, Mancia G.

J Hypertens Suppl. 1991 Dec;9(6):S110-1. No abstract available.

PMID:
1818904
29.

Effect of placebo on 24-h non-invasive ambulatory blood pressure.

Mutti E, Trazzi S, Omboni S, Parati G, Mancia G.

J Hypertens. 1991 Apr;9(4):361-4.

PMID:
1646263
30.

Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment.

Trazzi S, Mutti E, Frattola A, Imholz B, Parati G, Mancia G.

J Hypertens. 1991 Feb;9(2):115-9.

PMID:
1849525
31.

Advantages and disadvantages of non-invasive ambulatory blood pressure monitoring.

Parati G, Mutti E, Ravogli A, Trazzi S, Villani A, Mancia G.

J Hypertens Suppl. 1990 Dec;8(6):S33-8.

PMID:
2127944
32.

Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension.

Ravogli A, Trazzi S, Villani A, Mutti E, Cuspidi C, Sampieri L, De Ambroggi L, Parati G, Zanchetti A, Mancia G.

Hypertension. 1990 Nov;16(5):491-7.

PMID:
2228148
33.

Cardiovascular effects of smoking.

Mancia G, Groppelli A, Casadei R, Omboni S, Mutti E, Parati G.

Clin Exp Hypertens A. 1990;12(5):917-29. Review.

PMID:
2208758
34.

Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment.

Mancia G, Casadel R, Mutti E, Trazzi S, Parati G.

Am J Med. 1989 Dec 26;87(6B):64S-69S. Review.

PMID:
2690613
35.

Early twenty-four-hour blood pressure elevation in subjects with parental hypertension.

Parati G, Ravogli A, Trazzi S, Villani A, Mutti E, Groppelli A, Mancia G.

J Hypertens Suppl. 1989 Dec;7(6):S64-5.

PMID:
2632747
36.

Clinical and hemodynamic effects of celiprolol in essential hypertension.

Parati G, Ravogli A, Bragato R, Omboni S, Mutti E, Mancia G.

J Cardiovasc Pharmacol. 1989;14 Suppl 7:S14-21. Review.

PMID:
2481785
37.

24-h ambulatory non-invasive blood pressure monitoring in the assessment of the antihypertensive action of celiprolol.

Parati G, Pomidossi G, Casadei R, Ravogli A, Trazzi S, Mutti E, Mancia G.

J Int Med Res. 1988;16 Suppl 1:52A-61A.

PMID:
2975612
38.

[Combined isoniazid-heterocyclic thiosemicarbazone treatment of tuberculosis].

MUTTI E, PETRONE R.

Minerva Med. 1957 Mar 10;48(20):791-7. Italian. No abstract available.

PMID:
13430505

Supplemental Content

Support Center